|Videos|April 9, 2021

Raising Awareness Around Liver Cancer and Disease

CURE spoke with Dr. Marty T. Sellers and Dr. Laura M. Kulik, on behalf of the Blue Faery, about liver cancer and disease – its treatments, causes and areas outside of therapy.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content

Dr. Suneel Kamath discusses the importance of biomarker-driven approaches in cancer care following the 2026 ASCO GI Symposium.

Expert insights into Biomarker-Driven Care and Emerging Targets in GI Cancer

ByDr. Suneel Kamath

January 29th 2026

Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows

ByCURE staff

January 29th 2026

Caregivers Often Overlook Their Own Health While Supporting Patients

ByDr. Tracy Proverbs-Singh

January 29th 2026

A Breast Cancer Survivor’s First Brush with Skin Cancer

ByFelicia Mitchell

January 29th 2026

FDA Fast Tracks LBL-034 in Relapsed or Refractory Multiple Myeloma

ByCURE staff

January 29th 2026

Raising Awareness Around Liver Cancer and Disease

Newsletter

Related Content

Expert insights into Biomarker-Driven Care and Emerging Targets in GI Cancer

Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows

Caregivers Often Overlook Their Own Health While Supporting Patients

A Breast Cancer Survivor’s First Brush with Skin Cancer

FDA Fast Tracks LBL-034 in Relapsed or Refractory Multiple Myeloma

Trending on CURE

Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows

FDA Fast Tracks LBL-034 in Relapsed or Refractory Multiple Myeloma

Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC

Expert insights into Biomarker-Driven Care and Emerging Targets in GI Cancer

The Emotional Side of Cancer Care Beyond Medical Treatment